A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 2248
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : OS
Long Form : osteosarcoma
No. Year Title Co-occurring Abbreviation
2020 A 3D-printed biomaterials-based platform to advance established therapy avenues against primary bone cancers. 3DPDDS, DOX, mPCL
2020 A Bibliometric Analysis and Visualization of Current Research Trends in Chinese Medicine for Osteosarcoma. CM, WoS
2020 A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients. HR, miRNAs
2020 A comprehensive evaluation of single nucleotide polymorphisms associated with osteosarcoma risk: A protocol for systematic review and network meta-analysis. SNPs
2020 A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning. ROC
2020 A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma. ---
2020 Aberrant epigenetic silencing of neuronatin is a frequent event in human osteosarcoma. ER, NNAT
2020 Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors. ANOVA, CSCs, KLF4, SOX2
2020 Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells. MSCs
10  2020 Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes. LPS, TLR4
11  2020 ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-kappaB Pathway. ACTN4, HE
12  2020 ADAMTS7 degrades Comp to fuel BMP2-dependent osteogenic differentiation and ameliorate oncogenic potential in osteosarcomas. BMP, COMP
13  2020 Aerosolized Chemotherapy for Osteosarcoma. ---
14  2020 ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma. lncRNA, m6A, MeRIP, PVT1, RIP
15  2020 Analysis of Transcriptomic Similarity between Osteosarcoma Cell Lines and Primary Tumors. ---
16  2020 Anticancer effects and the mechanism underlying 2-methoxyestradiol in human osteosarcoma in vitro and in vivo. 2-ME, VEGF
17  2020 Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin. ---
18  2020 Aurora-B Promotes Osteosarcoma Cell Growth and Metastasis Through Activation of the NPM1/ERK/NF-kappabeta/MMPs Axis. IF
19  2020 Autophagy in Osteosarcoma. ---
20  2020 Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy. miRNAs
21  2020 beta-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2alpha/ATF4/CHOP activation and Wnt/beta-catenin signal suppression. beta-EA, CHOP, ER, UPR
22  2020 Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. BERA
23  2020 Biology and pathogenesis of human osteosarcoma. ---
24  2020 Bone Diseases: Current Approach and Future Perspectives in Drug Delivery Systems for Bone Targeted Therapeutics. NPs
25  2020 C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling. ---
26  2020 CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma. ---
27  2020 Cadmium in bone cement induces necrosis and decreases the viability of residual osteosarcoma cells: A xenograft study. ---
28  2020 Calycosin induces apoptosis in osteosarcoma cell line via ERbeta‑mediated PI3K/Akt signaling pathways. ER
29  2020 Camptothecin induced DDX5 degradation increased the camptothecin resistance of osteosarcoma. CPT
30  2020 CDKL3 promotes osteosarcoma progression by activating Akt/PKB. CDKL3
31  2020 CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition. CDKN2B-AS1, EMT, lncRNAs
32  2020 Characterization of LncRNA SNHG22 as a protector of NKIRAS2 through miR-4492 binding in osteosarcoma. ceRNA, EMT, HUVECs, LncRNA, NKIRAS2, SNHG22, SNHGs
33  2020 Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma. ALP, SUV
34  2020 Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours. CAR, EphA2, ES
35  2020 Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells. CGA
36  2020 Circ-XPO1 upregulates XPO1 expression by sponging multiple miRNAs to facilitate osteosarcoma cell progression. circRNAs
37  2020 Circ-XPR1 promotes osteosarcoma proliferation through regulating the miR-214-5p/DDX5 axis. circRNAs
38  2020 Circ0085539 Promotes Osteosarcoma Progression by Suppressing miR-526b-5p and PHLDA1 Axis. IHC, PHLDA1
39  2020 Circ100284 promotes invasion and migration of osteosarcoma cells by down-regulating PTEN and EMP1. CCK-8, ChIP, EMP1, EZH2, LSD1, PTEN, qRT-PCR
40  2020 CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. circRNAs, TXNIP
41  2020 CircEIF4G2 Promotes Tumorigenesis and Progression of Osteosarcoma by Sponging miR-218. circRNAs
42  2020 circKMT2D contributes to H2O2-attenuated osteosarcoma progression via the miR-210/autophagy pathway. circRNAs
43  2020 circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma. circRNA, EMT
44  2020 CircRNA Circ_0001721 Promotes the Progression of Osteosarcoma Through miR-372-3p/MAPK7 Axis. circRNAs, EMT, MAPK7, MTT, qRT-PCR, RIP
45  2020 CircSAMD4A regulates cell progression and epithelial‑mesenchymal transition by sponging miR‑342‑3p via the regulation of FZD7 expression in osteosarcoma. EMT, FZD7
46  2020 circSMARCA5 Promoted Osteosarcoma Cell Proliferation, Adhesion, Migration, and Invasion through a Competing Endogenous RNA Network. circRNAs
47  2020 CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/beta-catenin signaling pathway. circRNAs, miR-506-3p, qRT-PCR, SEMA6D
48  2020 Circular RNA 0060428 sponges miR-375 to promote osteosarcoma cell proliferation by upregulating the expression of RPBJ. circRNAs
49  2020 Circular RNA circCCDC66 Contributes to Malignant Phenotype of Osteosarcoma by Sponging miR-338-3p to Upregulate the Expression of PTP1B. circRNAs
50  2020 Circular RNA circFAT1(e2) Promotes Osteosarcoma Progression and Metastasis by Sponging miR-181b and Regulating HK2 Expression. ceRNA, circRNAs
51  2020 Circular RNA circHIPK3 Promotes Cell Metastasis through miR-637/STAT3 Axis in Osteosarcoma. ---
52  2020 Circular RNA CircITGA7 Promotes Tumorigenesis of Osteosarcoma via miR-370/PIM1 Axis. circRNA
53  2020 Circular RNA circTUBGCP3 Is Up-Regulated and Promotes Cell Proliferation, Migration and Survivability via Sponge mir-30b in Osteosarcoma. ---
54  2020 Circular RNA circUBAP2 regulates proliferation and invasion of osteosarcoma cells through miR-641/YAP1 axis. 3'UTR, CCK-8, circRNAs, EMT, qRT-PCR, YAP1
55  2020 Circular RNA circ_0000337 contributes to osteosarcoma via the miR-4458/BACH1 pathway. ---
56  2020 Circular RNA circ_0001105 Inhibits Progression and Metastasis of Osteosarcoma by Sponging miR-766 and Activating YTHDF2 Expression. circRNAs, ISH
57  2020 Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS. circRNAs
58  2020 Circular RNA hsa_circ_0001649 suppresses the growth of osteosarcoma cells via sponging multiple miRNAs. circRNA
59  2020 Circular RNA hsa_circ_0002052 promotes osteosarcoma via modulating miR-382/STX6 axis. circRNAs
60  2020 Circular RNA hsa_circ_0003496 Contributes to Tumorigenesis and Chemoresistance in Osteosarcoma Through Targeting (microRNA) miR-370/Kruppel-Like Factor 12 Axis. CCK-8, circRNAs, DXR, KLF12, qRT-PCR, RIP
61  2020 Circular RNA hsa_circ_0005909 modulates osteosarcoma progression via the miR-936/HMGB1 axis. CCK-8, EMT, HMGB1, qRT-PCR
62  2020 Circular RNA PVT1 promotes metastasis via regulating of miR-526b/FOXC2 signals in OS cells. circPVT1, circRNAs, miR-526b, MREs
63  2020 Circular RNA_CNST Promotes the Tumorigenesis of Osteosarcoma Cells by Sponging miR-421. circRNAs, FISH, PCR
64  2020 Circ_0000285 regulates proliferation, migration, invasion and apoptosis of osteosarcoma by miR-409-3p/IGFBP3 axis. circRNAs, IGFBP-3, qRT-PCR, RIP
65  2020 Circ_0000885 Enhances Osteosarcoma Progression by Increasing FGFR1 Expression via Sponging MiR-1294. circRNAs, FGFR1, qRT-PCR, WB
66  2020 Circ_0001658 promotes the proliferation and metastasis of osteosarcoma cells via regulating miR-382-5p/YB-1 axis. circRNA, miRNA, YB-1
67  2020 circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression. ---
68  2020 Circ_SIPA1L1 Promotes Osteosarcoma Progression Via miR-379-5p/MAP3K9 Axis. circRNAs, circ_SIPA1L1, miR-379-5p, qRT-PCR
69  2020 Clinical Outcome of Free Vascularized Fibula Graft in the Surgical Treatment of Extremity Osteosarcoma. FVFG, MSTS
70  2020 Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas. CSCs, CXCR4
71  2020 Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma. GO, KEGG, LASSO, WGCNA
72  2020 Cold atmospheric plasma inhibits the growth of osteosarcoma cells by inducing apoptosis, independent of the device used. CAP
73  2020 Cold Plasma-Treated Ringer's Saline: A Weapon to Target Osteosarcoma. PAR
74  2020 Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma. EF, NAs, SQgem
75  2020 Comparison of serum cytokine concentrations between healthy dogs and canine osteosarcoma patients at the time of diagnosis. IL-12p40, IL-8
76  2020 Comprehensive characterization of circular RNAs in osteosarcoma cell lines. ceRNA, circRNA, EMT
77  2020 Comprehensive Characterization of Prognostic Long Noncoding RNAs in Osteosarcoma. CNA, GO, KEGG, lncRNAs
78  2020 Conditioned medium of the osteosarcoma cell line U2OS induces hBMSCs to exhibit characteristics of carcinoma-associated fibroblasts via activation of IL-6/STAT3 signalling. BMSCs, CAFs, hBMSCs, U2OS
79  2020 Confocal Raman microspectroscopic analysis on the time-dependent impact of DAPT, a gamma-secretase inhibitor, to osteosarcoma cells. CRM, KCA, LDA, PCA, UT
80  2020 Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma. circRNAs, GEO, GO, KEGG
81  2020 Construction of an integrated human osteosarcoma database, HOsDb, based on literature mining, microarray analysis, and database retrieval. miRNAs, SNPs, TFs
82  2020 Correlation between the changes of serum COX 2, APE1, VEGF, TGF-beta and TSGF levels and prognosis in patients with osteosarcoma before and after treatment. bFGF, COX-2, TGF-beta, TSGF, VEGF
83  2020 Cyanidin 3-O-Glucoside Induces the Apoptosis in the Osteosarcoma Cells through Upregulation of the PPARgamma and P21: An In Vitro Study. C3G, PCR
84  2020 Cytological diagnosis of osteosarcoma with emphasis on diagnostic pitfalls. ---
85  2020 Dedifferentiated low-grade central osteosarcoma with extensive cystic change initially treated as a simple bone cyst. LG-COS
86  2020 Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities. ---
87  2020 Development of a novel immune-related genes prognostic signature for osteosarcoma. DEIRGs, GTEx, IRGs
88  2020 Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release. CPCs, DOXO, MSCs, NPs
89  2020 DHRS12 inhibits the proliferation and metastasis of osteosarcoma via Wnt3a/beta-catenin pathway. ---
90  2020 Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells. AURKA, DEGs
91  2020 Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo. GSDME, PCD
92  2020 Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune Therapy. CSV, CTCs, IL-12
93  2020 Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300. ---
94  2020 Down-regulation of MIAT suppresses osteosarcoma progression by acting as a ceRNA for miR-141-3p to regulate SIX1-mediated PI3K/AKT pathway. MIAT, PI3K, SIX1
95  2020 Down-regulation of miR-10b represses cell vitality in osteosarcoma and is inversely associated with prognosis via interacting with FAM46C: Running title: MiR-10b/FAM46C axis modulates OS progression. CCK-8, GEO
96  2020 Down-regulation of PDGFRbeta suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition. mTOR, PDGFR, PI3K
97  2020 Down-Regulation of Ribosomal Protein RPS21 Inhibits Invasive Behavior of Osteosarcoma Cells Through the Inactivation of MAPK Pathway. CCK-8, GEO, MAPK, qRT-PCR, RPS21
98  2020 Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. CDK6, lncRNA, miR, RT-qPCR
99  2020 Downregulation of CDC20 suppressed cell proliferation, induced apoptosis, triggered cell cycle arrest in osteosarcoma cells, and enhanced chemosensitivity to cisplatin. CDC20
100  2020 Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p. IGF1R, lncSNHG12